BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for ESSA Pharma Inc. (EPIX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for ESSA Pharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-09
09:00 am
Unchanged		 2025-04-09 13D ESSA Pharma Inc.
EPIX		 BIOTECHNOLOGY VALUE FUND L P 8,748,629
19.700%		 0
(Unchanged)		 Filing
2022-07-12
4:40 pm
Purchase		 2022-07-08 13G ESSA Pharma Inc.
EPIX		 BIOTECHNOLOGY VALUE FUND L P 8,748,629
19.900%		 4,183,387increase
(+91.64%)		 Filing
2022-02-14
1:43 pm
Purchase		 2021-12-31 13G ESSA Pharma Inc.
EPIX		 BIOTECHNOLOGY VALUE FUND L P 4,565,242
9.990%		 859,953increase
(+23.21%)		 Filing
2021-02-11
5:20 pm
Purchase		 2020-12-31 13G ESSA Pharma Inc.
EPIX		 BIOTECHNOLOGY VALUE FUND L P 3,705,289
11.000%		 1,064,724increase
(+40.32%)		 Filing